This year’s Nordic Life Science Days took place in Copenhagen on 29-30 November. Since 2015, Oslo Cancer Cluster has coordinated the joint booth Norway for Life Science, promoting the Norwegian healthcare and life science industry. This year together with Norway Health Tech, The Life Science Cluster, Norwegian Smart Care Cluster, Centre for Digital Life Norway, […]
The foundations of the ECHoS project are laid and Cancer Mission activities are speeding up in Norway.
Are polygenic risk scores the answer?
Thomas London has joined the board of Oslo Cancer Cluster Incubator.
How can manufacturing of T cell therapies be improved?
New data shows 27% improved survival in the NIPU trial.
Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.
SurViva is a Norwegian consultancy providing quality guidance for life science companies.
New Norwegian research in polygenic risk score
What is the government's ambition for the health industry?
Smaller patient groups and targeted treatments are the future of cancer care in Norway. It is no longer a question of if but when personalised medicine will be a reality for all cancer patients in Norway. This was a key message in a recent meeting arranged by the public-private consortium CONNECT during Arendalsuka, where the […]
How will Norway implement the Mission on Cancer?